Asthma Epidemiology - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Asthma Epidemiology

Description:

More than 22 million people in the US have asthma, of these 6 million are children ... to environmental antigens (house-dust mite, cockroach, Alternaria, cat) ... – PowerPoint PPT presentation

Number of Views:579
Avg rating:3.0/5.0
Slides: 23
Provided by: lawrenc71
Category:

less

Transcript and Presenter's Notes

Title: Asthma Epidemiology


1
Asthma Epidemiology
  • LCDR Potter
  • Pediatrics
  • NH Jacksonville

2
  • Statistics
  • More than 22 million people in the US have
    asthma, of these 6 million are children
  • Nearly 5,000 Americans die of asthma each year.
  • Asthma accounts for 2 million emergency room
    visits and 500,000 hospitalizations annually.

3
(No Transcript)
4
Asthma Definition
  • Asthma is a common chronic disorder of the
    airways that is complex and characterized by
    variable and recurring symptoms, reversible
    airflow obstruction, bronchial hyper-responsivenes
    s, and an underlying inflammation.
  • airway infiltrates of mast cells, eosinophils,
    neutrophils (smokers and severe asthmatics), T
    lymphocytes, macrophages and epithelial cells.
  • Susceptible individuals experience recurrent
    cough (esp. at night), wheezing, breathlessness
    and chest tightness.

5
Asthma Definition
  • These episodes are usually associated with
    widespread but variable airflow obstruction that
    is often reversible either spontaneously or with
    treatment.
  • The inflammation also causes an associated
    increase in the existing bronchial
    hyper-responsiveness to a variety of stimuli.
  • Reversibility of airflow limitation may be
    incomplete in some patients with asthma.

6
Inflammation and Clinical Symptoms
Inflammation
Airway Hyper-responsiveness
Airway Obstruction
Clinical Symptoms
7
Bronchoconstriction
  • In acute exacerbations of asthma, bronchial
    smooth muscle contraction (bronchoconstriction)
    occurs quickly to narrow the airways in response
    to exposure to a variety of stimuli including
    allergens or irritants.
  • Allergen-induced acute bronchoconstriction
  • IgE-dependent release of mediators from mast
    cells histamine, tryptase, leukotrienes, and
    prostaglandins
  • Aspirin and other non-steroidal anti-inflammatory
    drugs can also cause acute airflow obstruction in
    some patients
  • non-IgE-dependent response
  • Other stimuli exercise, cold air, and irritants
    can cause acute airflow obstruction.
  • intensity of the response appears related to
    underlying airway inflammation.

8
(No Transcript)
9
Airway Hyper-responsiveness
  • Exaggerated bronchoconstrictor response to a wide
    variety of stimuliis directly affected by the
    degree of airway inflammation.
  • Airway hyper-responsiveness directly correlates
    with the clinical severity of asthma.
  • Demonstrated by degree of responsiveness on
    testing such as Methacholine challenge.
  • The mechanisms influencing airway
    hyper-responsiveness are multiple and include
    inflammation, dysfunctional neuroregulation, and
    structural changes.
  • Treatment directed toward reducing inflammation
    can reduce airway hyper-responsiveness and
    improve asthma control.

10
Airway Edema
  • As the inflammatory process progresses the
    airways become plugged and obstructed by
  • Edema
  • Mucous hypersecretion
  • Inspissated mucous plugs
  • PERMANENT airway remodeling begins sub-basement
    fibrosis, epithelial injury, smooth muscle
    hypertrophy, angiogenesis

11
(No Transcript)
12
(No Transcript)
13
Asthma Pathogenesis
  • The expression of asthma is a complex,
    interactive process that depends on the interplay
    between two major factors
  • host factors (particularly genetics allergic,
    Beta receptors polymorphisms, innate immunity)
  • environmental exposures (allergen sensitization
    and viruses)
  • The combination of host factors and environmental
    exposures at critical times in the immune system
    development determine the expression of asthma
    symptoms.

14
Asthma Pathogenesis
  • Host Factors Innate Immunity
  • Imbalance between Th1 and Th2 cytokine profiles.
  • Evidence that allergic diseases, and possibly
    asthma, are characterized by a shift toward a Th2
    cytokine-like disease.
  • Th1 cells produce IL-2 and interferon-? (IFN-?),
    which are critical in cellular defense mechanisms
    in response to infection.
  • Th2, in contrast, generates a family of cytokines
    (IL-4, -5, -6, -9, and -13) that can mediate
    allergic inflammation.

15
Asthma Pathogenesis
  • Hygiene Hypothesis hypothesis is based on the
    assumption that the immune system of the newly
    born is skewed toward Th2 cytokine generation.
  • Following birth, environmental stimuli such as
    infections will activate Th1 responses and bring
    the Th1/Th2 relationship to an appropriate
    balance.
  • The incidence of asthma is reduced in association
    with certain infections (M. tuberculosis,
    measles, or hepatitis A), exposure to other
    children and less frequent use of antibiotics.
  • The absence of the these lifestyle events is
    associated with the persistence of a Th2 cytokine
    pattern promote the production of IgE antibodies
    to environmental antigens (house-dust mite,
    cockroach, Alternaria, cat).

16
(No Transcript)
17
Environmental Triggers
  • Two major environmental factors have emerged as
    the most important in the development,
    persistence, and possibly severity of asthma
  • airborne allergens and viral respiratory
    infections
  • Allergens
  • Sensitization and exposure to house-dust mite and
    Alternaria are important factors in the
    development of asthma in children.
  • Cock roach sensitization in inner city dwellings
    is particularly problematic.
  • Earlier concerns for exposure to dog and cats
    early in life have not been borne out in long
    term outcome studies

18
Environmental Triggers
  • Respiratory Infections During infancy, a number
    of respiratory viruses have been associated with
    the inception or development of asthma.
  • Respiratory syncytial virus (RSV) and
    parainfluenza virus in particular, cause
    bronchiolitis and recurrent wheezing that
    parallels many features of childhood asthma.
  • A number of long-term prospective studies of
    children admitted to hospital with documented RSV
    have shown that approximately 40 percent of these
    infants will continue to wheeze or have asthma in
    later childhood.
  • Symptomatic rhinovirus infections in early life
    also are emerging as risk factors for recurrent
    wheezing.

19
Environmental Triggers
  • In utero exposure to environmental tobacco smoke
    increases the likelihood for wheezing in the
    infant, although the subsequent development of
    asthma has not been well defined.
  • In adults who have asthma, cigarette smoking has
    been associated with an increase in asthma
    severity and decreased responsiveness to inhaled
    corticosteroids.

20
Environmental Triggers
  • One recent epidemiologic study showed that heavy
    exercise outdoors in communities with high
    concentration of ozone was associated with a
    higher risk of asthma among school-age children.
  • The relationship between increased levels of
    pollution and increases in asthma exacerbations
    and emergency care visits has been well
    documented.

21
Inflammatory mediators
  • IgE is the antibody responsible for activation of
    allergic reactions.
  • IgE attaches to cell surfaces via a specific
    high-affinity receptor.
  • The mast cell has large numbers of IgE receptors
    which cause the release of mediators to initiate
    acute bronchospasm as well as cytokines to
    perpetuate underlying airway inflammation.
  • Omalizumab a monoclonal antibody against IgE has
    shown that the reduction of IgE is effective in
    asthma treatment.

22
Treatment Implications
  • Current therapies
  • prevent occurrences of exacerbations.
  • reduce inflammation.
  • do not prevent the progression of disease in
    affected children.
  • New therapies for asthma management will be
    necessary to preserve lung function and prevent
    disease progression.
Write a Comment
User Comments (0)
About PowerShow.com